Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
American Heart Journal Plus : Cardiology Research and Practice|July 5, 2022
Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery diseaseOdayme Quesada, Omeed Elboudwarej, Michael D Nelson, et al.
NEJM Evidence|February 6, 2024
Outpatient Randomized Controlled Trials in the Covid-19 Era and BeyondJean M Connors, Maria M Brooks, Frank C Sciurba, et al.
Journal of the American College of Cardiology|February 7, 2006
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyLeslee J Shaw, Marian B Olson, Kevin Kip, et al.
Communications Medicine|May 28, 2026
Artificial intelligence-enabled plaque characterization from coronary computed tomography establishes basis of angina in women with nonobstructive atherosclerosisRafal Wolny, Guadalupe Flores Tomasino, Kajetan Grodecki, et al.
JAMA Cardiology|July 24, 2024
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical TrialJennifer A Rymer, Hillary Mulder, Lisa M Wruck, et al.
Atherosclerosis|September 7, 2016
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)Girum Mekonnen, Salim S Hayek, Puja K Mehta, et al.
BMC Infectious Diseases|May 15, 2023
Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trialJoseph Bledsoe, Scott C Woller, Maria Brooks, et al.
Contemporary Clinical Trials|August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platformAnne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.
JAMA|October 11, 2021
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical TrialJean M Connors, Maria M Brooks, Frank C Sciurba, et al.
JAMA|March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialEmerson C Perin, James T Willerson, Carl J Pepine, et al.
Pageof 8